Corebridge Financial Inc
For the period ended Dec 31, 2024. Filed Feb 13, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 13, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Report of Independent Registered Public Accounting Firm
To the Board of Directors and Shareholders of Corebridge Financial, Inc.
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheets of Corebridge Financial, Inc. and its subsidiaries (the “Company”) as of December 31, 2024 and 2023, and the related consolidated statements of income (loss), comprehensive income (loss), of equity and of cash flows for each of the three years in the period ended December 31, 2024, including the related notes and financial statement schedules listed in the accompanying index (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Corebridge | 2024 Form 10-K 148
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
Valuation of Certain Level 3 Fixed Maturity Securities
As described in Note 4 to the consolidated financial statements, as of December 31, 2024, the total fair value of the Company’s level 3 fixed maturity securities, including bonds available-for-sale and other bond securities, was $30.5 billion, comprised of residential mortgage backed securities, commercial mortgage backed securities, collateralized loan obligations, other asset-backed securities, and fixed maturity securities issued by corporations (including private placements), states and municipalities. As the volume or level of market activity for these securities is limited, management determines fair value either by requesting brokers who are knowledgeable about the particular security to provide a price quote, which according to management is generally non-binding, or by employing market accepted valuation models. In both cases, certain inputs used by management to determine fair value may not be observable in the market. For certain private placement securities, fair value is determined by management based on discounted cash flow models using discount rates based on credit spreads, yields or price levels of comparable securities, adjusted for illiquidity and structure. For other level 3 fixed maturity securities, such assumptions may include loan delinquencies and defaults, loss severity, and prepayments. As disclosed by management, fair value estimates are subject to management review to ensure valuation models and related inputs are reasonable.
The principal considerations for our determination that performing procedures relating to the valuation of certain level 3 fixed maturity securities is a critical audit matter are (i) the significant judgment by management to determine the fair value of these securities, which in turn led to a high degree of auditor subjectivity and judgment in performing the audit procedures relating to the aforementioned assumptions that are used to determine the fair value, (ii) the significant audit effort and judgment in evaluating the audit evidence related to the valuation and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the valuation of level 3 fixed maturity securities, including controls related to (i) management’s review over the pricing function and (ii) identifying and resolving pricing exceptions. These procedures also included, among others, obtaining independent third party vendor pricing, where available, and the involvement of professionals with specialized skill and knowledge to assist in developing an independent range of prices for a sample of securities. Developing the independent range of prices involved testing the completeness and accuracy of data provided by management on a sample basis and evaluating the reasonableness of management’s assumptions noted above. The independent third party vendor pricing and the independently developed ranges were compared to management’s recorded fair value estimates.
Valuation of Market Risk Benefits (MRBs) on Individual Retirement Variable and Fixed Index Annuity contracts and the valuation of Embedded Derivatives (EDs) for certain Guaranteed Benefit Features on Fixed Index Annuity contracts
As described in Notes 4, 13, and 14 to the consolidated financial statements, the total fair value of the individual retirement MRB assets and liabilities were $1,124 million and $5,130 million, respectively and the fair value of the embedded derivatives for certain guaranteed features on fixed index annuity contracts was $1.8 billion at December 31, 2024. Certain variable annuity and fixed index annuity contracts contain MRBs related to guaranteed benefit features that management separates from the host contracts and accounts for at fair value. As disclosed by management, the fair value of MRBs contained in certain variable and fixed index annuity contracts and the associated EDs for certain guaranteed features on fixed index annuities is measured based on policyholder behavior and capital market assumptions related to projected cash flows over the expected lives of the contracts. The projected cash flows incorporate best estimate assumptions for policyholder behavior (including lapses, withdrawals and benefit utilization), along with an explicit risk margin to reflect a market participant’s estimates of the fair value of projected cash flows and policyholder behavior. Estimating the underlying cash flows for these features also involves judgments regarding the capital market assumptions including expected market rates of return, market volatility, credit spreads, correlations of certain market variables, fund performance and discount rates. The guaranteed product features in the fixed index annuity contracts that are not MRBs and are accounted for as EDs utilize option pricing models to estimate fair value, taking into account the capital market assumptions for future index growth rates, volatility of the index, future interest rates, and the Company’s ability to adjust the participation rate and the cap on fixed index credited rates in light of market conditions and policyholder behavior assumptions.
Corebridge | 2024 Form 10-K 149
The principal considerations for our determination that performing procedures relating to the valuation of MRBs on individual retirement variable and fixed index annuity contracts and EDs for certain guaranteed benefit features on fixed index contracts is a critical audit matter are (i) the significant judgment by management in developing policyholder behavior assumptions relating to the individual retirement variable and fixed index annuity lapses, withdrawals and benefit utilization, along with an explicit risk margin used in the valuation of the MRBs and EDs for certain guaranteed benefit features on fixed index contracts (collectively the “significant assumptions”), (ii) a high degree of auditor judgment, subjectivity and effort in performing procedures and evaluating management’s significant assumptions, and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the development of assumptions used in the valuation of MRBs on individual retirement variable and fixed index annuity contracts and the EDs for certain guaranteed benefit features on fixed index contracts. These procedures also included, among others, (i) testing management’s process for developing the valuation of the MRBs and EDs for certain guaranteed benefit features on fixed index contracts, (ii) testing, on a sample basis, the completeness and accuracy of data used by management to develop the significant assumptions, (iii) testing that the significant assumptions are accurately reflected in the models, and (iv) the involvement of professionals with specialized skill and knowledge to assist in evaluating the reasonableness of management’s judgments used in developing the significant assumptions based on industry knowledge and data.
/s/PricewaterhouseCoopers LLP
New York, New York
February 13, 2025
We have served as the Company’s auditor since 2020.
Corebridge | 2024 Form 10-K 150
| (in millions, except for share data) | December 31, 2024 | December 31, 2023 |
|---|---|---|
| Assets: | ||
| Investments: | ||
| Fixed maturity securities: | ||
| Bonds available-for-sale, at fair value, net of allowance for credit losses of $119 in 2024 and $128 in 2023 (amortized cost: 2024 - $191,058; 2023 - $184,946)* | $170,840 | $166,527 |
| Other bond securities, at fair value (See Note 5)* | 5,262 | 4,578 |
| Equity securities, at fair value (See Note 5)* | 56 | 63 |
| Mortgage and other loans receivable, net of allowance for credit losses of $771 in 2024 and $698 in 2023* | 52,768 | 46,867 |
| Other invested assets (portion measured at fair value: 2024 - $7,791; 2023 - $7,690)* | 9,851 | 10,257 |
| Short-term investments, including restricted cash of $4 in 2024 and $3 in 2023 (portion measured at fair value: 2024 - $1,439; 2023 - $1,408)* | 4,981 | 4,336 |
| Total investments | 243,758 | 232,628 |
| Cash* | 806 | 612 |
| Accrued investment income* | 2,169 | 2,008 |
| Premiums and other receivables, net of allowance for credit losses and disputes of $1 in 2024 and $1 in 2023 | 713 | 594 |
| Reinsurance assets - Fortitude Re, net of allowance for credit losses and disputes of $— in 2024 and $— in 2023 | 24,933 | 26,772 |
| Reinsurance assets - other, net of allowance for credit losses and disputes of $12 in 2024 and $30 in 2023 | 1,560 | 1,620 |
| Deferred income taxes | 7,903 | 8,577 |
| Deferred policy acquisition costs and value of business acquired | 10,293 | 10,011 |
| Market risk benefit assets, at fair value | 1,332 | 912 |
| Other assets, including restricted cash of $14 in 2024 and $13 in 2023 (portion measured at fair value: 2024 - $193; 2023 - $393)* | 1,844 | 2,294 |
| Separate account assets, at fair value | 93,888 | 91,005 |
| Assets held-for-sale | 198 | 2,237 |
| Total assets | $389,397 | $379,270 |
| Liabilities: | ||
| Future policy benefits for life and accident and health insurance contracts | $56,272 | $57,108 |
| Policyholder contract deposits (portion measured at fair value: 2024 - $9,535; 2023 - $8,050) | 173,695 | 162,050 |
| Market risk benefit liabilities, at fair value | 5,616 | 5,705 |
| Other policyholder funds | 2,873 | 2,862 |
| Fortitude Re funds withheld payable (portion measured at fair value: 2024 - $2,223; 2023 - $2,182) | 24,291 | 25,957 |
| Other liabilities (portion measured at fair value: 2024 - $110; 2023 - $141)* | 8,044 | 8,330 |
| Short-term and long-term debt, of which $1,101 is short-term debt in 2024 and $250 in 2023 | 10,454 | 9,368 |
| Debt of consolidated investment entities (portion measured at fair value: 2024 - $0; 2023 - $0)* | 1,938 | 2,504 |
| Separate account liabilities | 93,888 | 91,005 |
| Liabilities held-for-sale | — | 1,746 |
| Total liabilities | $377,071 | $366,635 |
| Contingencies, commitments and guarantees (See Note 16) | ||
| Corebridge Shareholders' equity: | ||
| Common stock, $0.01 par value; 2,500,000,000 shares authorized; shares issued: 2024 - 650,189,849 and 2023 - 648,148,737 | $7 | $6 |
| Treasury stock, at cost; 2024 - 88,704,816 shares and 2023 - 26,484,411 shares | (2,282) | (503) |
| Additional paid-in capital | 8,161 | 8,149 |
| Retained earnings | 19,257 | 17,572 |
| Accumulated other comprehensive loss | (13,681) | (13,458) |
| Total Corebridge Shareholders' equity | 11,462 | 11,766 |
| Non-redeemable noncontrolling interests | 864 | 869 |
| Total equity | 12,326 | 12,635 |
| Total liabilities and equity | $389,397 | $379,270 |
*See Note 8 for details of balances associated with variable interest entities.
Corebridge | 2024 Form 10-K 151
| Years Ended December 31, | |||
|---|---|---|---|
| (in millions, except per common share data) | 2024 | 2023 | 2022 |
| Revenues: | |||
| Premiums | $4,600 | $7,691 | $5,091 |
| Policy fees | 2,901 | 2,797 | 2,914 |
| Net investment income: | |||
| Net investment income - excluding Fortitude Re funds withheld assets | 10,858 | 9,710 | 8,685 |
| Net investment income - Fortitude Re funds withheld assets | 1,370 | 1,368 | 891 |
| Total net investment income | 12,228 | 11,078 | 9,576 |
| Net realized gains (losses): | |||
| Net realized gains (losses) - excluding Fortitude Re funds withheld assets and embedded derivative | (1,117) | (1,614) | 141 |
| Net realized gains (losses) on Fortitude Re funds withheld assets | (248) | (224) | (397) |
| Net realized gains (losses) on Fortitude Re funds withheld embedded derivative | (518) | (1,734) | 6,347 |
| Total net realized gains (losses) | (1,883) | (3,572) | 6,091 |
| Advisory fee income | 506 | 467 | 475 |
| Other income | 429 | 417 | 550 |
| Total revenues | 18,781 | 18,878 | 24,697 |
| Benefits and expenses: | |||
| Policyholder benefits (includes remeasurement losses of $403, $342 and $298 for the years ended December 31, 2024, 2023 and 2022, respectively) | 6,632 | 9,362 | 6,720 |
| Change in the fair value of market risk benefits, net | (227) | (6) | (958) |
| Interest credited to policyholder account balances | 5,240 | 4,427 | 3,732 |
| Amortization of deferred policy acquisition costs and value of business acquired | 1,060 | 1,042 | 1,020 |
| Non-deferrable insurance commissions | 588 | 588 | 568 |
| Advisory fee expenses | 286 | 261 | 266 |
| General operating expenses | 2,090 | 2,360 | 2,323 |
| Interest expense | 554 | 580 | 534 |
| Net (gain) loss on divestitures | (245) | (676) | 1 |
| Total benefits and expenses | 15,978 | 17,938 | 14,206 |
| Income (loss) before income tax expense (benefit) | 2,803 | 940 | 10,491 |
| Income tax expense (benefit): | |||
| Current | (35) | 306 | 878 |
| Deferred | 635 | (402) | 1,134 |
| Income tax expense (benefit) | 600 | (96) | 2,012 |
| Net income (loss) | 2,203 | 1,036 | 8,479 |
| Less: | |||
| Net income (loss) attributable to noncontrolling interests | (27) | (68) | 320 |
| Net income (loss) attributable to Corebridge | $2,230 | $1,104 | $8,159 |
| Income (loss) per common share attributable to Corebridge common shareholders: | |||
| Common stock - basic | $3.73 | $1.72 | $12.63 |
| Common stock - diluted | $3.72 | $1.71 | $12.60 |
| Weighted average shares outstanding: | |||
| Common stock - basic | 598.0 | 643.3 | 646.1 |
| Common stock - diluted | 599.2 | 645.2 | 647.4 |
Corebridge | 2024 Form 10-K 152
| Years Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2024 | 2023 | 2022 |
| Net income (loss) | $2,203 | $1,036 | $8,479 |
| Other comprehensive income (loss), net of tax | |||
| Change in unrealized appreciation (depreciation) of fixed maturity securities on which allowance for credit losses was taken | 36 | 13 | (61) |
| Change in unrealized appreciation (depreciation) of all other investments | (1,540) | 4,730 | (31,695) |
| Change in fair value of market risk benefits attributable to changes in our own credit risk | 219 | (544) | 1,294 |
| Change in the discount rates used to measure traditional and limited payment long-duration insurance contracts | 1,247 | (813) | 5,298 |
| Change in cash flow hedges | (193) | (11) | 157 |
| Change in foreign currency translation adjustments | 54 | 48 | (101) |
| Change in retirement plan liabilities | — | (7) | 2 |
| Other comprehensive income (loss) | (177) | 3,416 | (25,106) |
| Comprehensive income (loss) | 2,026 | 4,452 | (16,627) |
| Less: | |||
| Comprehensive income (loss) attributable to noncontrolling interests | (19) | (57) | 310 |
| Comprehensive income (loss) attributable to Corebridge | $2,045 | $4,509 | $(16,937) |
Corebridge | 2024 Form 10-K 153
Corebridge Financial, Inc. Consolidated Statements of Equity
| (in millions) · Common Stock · CommonStockClass A · CommonStockClass B · Treasury Stock · AdditionalPaid-InCapital · RetainedEarnings · AccumulatedOtherComprehensiveIncome (Loss) · TotalCorebridgeShareholders' Equity · Non-RedeemableNoncontrollingInterests · TotalShareholders'Equity | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance, December 31, 2021 | $— | $5 | $1 | $— | $8,054 | $10,937 | $8,233 | $27,230 | $1,759 | $28,989 | ||||||
| Net income attributable to Corebridge or noncontrolling interests | — | — | — | — | — | 8,159 | — | 8,159 | 320 | 8,479 | ||||||
| Dividends on common stock | — | — | — | — | — | (876) | — | (876) | — | (876) | ||||||
| Other comprehensive loss, net of tax | — | — | — | — | — | — | (25,096) | (25,096) | (10) | (25,106) | ||||||
| Changes in noncontrolling interests due to divestitures and acquisitions | — | — | — | — | — | — | — | — | (104) | (104) | ||||||
| Contributions from noncontrolling interests | — | — | — | — | — | — | — | — | 155 | 155 | ||||||
| Distributions to noncontrolling interests | — | — | — | — | — | — | — | — | (1,181) | (1,181) | ||||||
| Other | — | — | — | — | (24) | (13) | — | (37) | — | (37) | ||||||
| Reorganization transactions | 6 | (5) | (1) | — | — | — | — | — | — | — | ||||||
| Balance, December 31, 2022 | $6 | $— | $— | $— | $8,030 | $18,207 | $(16,863) | $9,380 | $939 | $10,319 | ||||||
| Purchase of common stock | — | — | — | (503) | — | — | — | (503) | — | (503) | ||||||
| Net income (loss) attributable to Corebridge or noncontrolling interests | — | — | — | — | — | 1,104 | — | 1,104 | (68) | 1,036 | ||||||
| Dividends on common stock | — | — | — | — | — | (1,722) | — | (1,722) | — | (1,722) | ||||||
| Other comprehensive income, net of tax | — | — | — | — | — | — | 3,405 | 3,405 | 11 | 3,416 | ||||||
| Changes in noncontrolling interests due to divestitures and acquisitions | — | — | — | — | — | — | — | (19) | (19) | |||||||
| Contributions from noncontrolling interests | — | — | — | — | — | — | — | — | 96 | 96 | ||||||
| Distributions to noncontrolling interests | — | — | — | — | — | — | — | — | (91) | (91) | ||||||
| Other | — | — | — | — | 119 | (17) | — | 102 | 1 | 103 | ||||||
| Balance, December 31, 2023 | $6 | $— | $— | $(503) | $8,149 | $17,572 | $(13,458) | $11,766 | $869 | $12,635 | ||||||
Corebridge | 2024 Form 10-K 154
Corebridge Financial, Inc. Consolidated Statements of Equity (continued)
| (in millions) | Common Stock | CommonStockClass A | CommonStockClass B | Treasury Stock | AdditionalPaid-InCapital | RetainedEarnings | AccumulatedOtherComprehensiveIncome (Loss) | TotalCorebridgeShareholders' Equity | Non-RedeemableNoncontrollingInterests | TotalShareholders'Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance, December 31, 2023 | $6 | $— | $— | $(503) | $8,149 | $17,572 | $(13,458) | $11,766 | $869 | $12,635 |
| Common stock issued under stock plans | 1 | — | — | 24 | (24) | — | — | 1 | — | 1 |
| Purchase of common stock | — | — | — | (1,803) | — | — | — | (1,803) | — | (1,803) |
| Net income (loss) attributable to Corebridge or noncontrolling interests | — | — | — | — | — | 2,230 | — | 2,230 | (27) | 2,203 |
| Dividends on common stock | — | — | — | — | — | (544) | — | (544) | — | (544) |
| Other comprehensive income (loss), net of tax | — | — | — | — | — | — | (185) | (185) | 8 | (177) |
| Changes in noncontrolling interests due to divestitures and acquisitions | — | — | — | — | — | — | — | — | 145 | 145 |
| Contributions from noncontrolling interests | — | — | — | — | — | — | — | — | 70 | 70 |
| Distributions to noncontrolling interests | — | — | — | — | — | — | — | — | (199) | (199) |
| Other | — | — | — | — | 36 | (1) | (38) | (3) | (2) | (5) |
| Balance, December 31, 2024 | $7 | $— | $— | $(2,282) | $8,161 | $19,257 | $(13,681) | $11,462 | $864 | $12,326 |
Corebridge | 2024 Form 10-K 155
| Years Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2024 | 2023 | 2022 |
| Cash flows from operating activities: | |||
| Net income (loss) | $2,203 | $1,036 | $8,479 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Non-cash revenues, expenses, gains and losses included in income (loss): | |||
| Net losses (gains) on sales of securities available-for-sale and other assets | 1,049 | 304 | 377 |
| Net (gain) loss on divestitures | (245) | (676) | 1 |
| Unrealized (gains) losses in earnings - net | 870 | 1,797 | 864 |
| Change in the fair value of market risk benefits in earnings, net | (831) | (348) | (1,481) |
| Equity in income from equity method investments, net of dividends or distributions | 65 | 8 | (97) |
| Depreciation and other amortization | 193 | 366 | 585 |
| Impairments of assets | 69 | 69 | 25 |
| Changes in operating assets and liabilities: | |||
| Insurance liabilities | 980 | 770 | 996 |
| Premiums and other receivables and payables - net | (167) | (265) | 40 |
| Funds held relating to Fortitude Re Reinsurance contracts | (1,420) | (137) | (8,497) |
| Reinsurance assets and funds held under reinsurance treaties | 825 | 675 | 1,086 |
| Capitalization of deferred policy acquisition costs | (1,377) | (1,260) | (1,059) |
| Current and deferred income taxes - net | 349 | (116) | 912 |
| Other, net | (412) | 1,134 | 390 |
| Total adjustments | (52) | 2,321 | (5,858) |
| Net cash provided by operating activities | 2,151 | 3,357 | 2,621 |
| Cash flows from investing activities: | |||
| Proceeds from (payments for) | |||
| Sales or distributions of: | |||
| Available-for-sale securities | 8,080 | 7,400 | 10,566 |
| Other securities | 1,113 | 988 | 2,181 |
| Other invested assets | 1,733 | 1,367 | 1,888 |
| Divestitures, net | 577 | 747 | — |
| Maturities of fixed maturity securities available-for-sale | 16,164 | 8,859 | 9,621 |
| Principal payments received on mortgage and other loans receivable | 5,509 | 6,164 | 7,814 |
| Purchases of: | |||
| Available-for-sale securities | (29,644) | (18,321) | (19,499) |
| Other securities | (1,669) | (1,379) | (3,694) |
| Other invested assets | (924) | (1,172) | (1,662) |
| Mortgage and other loans receivable | (11,878) | (9,168) | (14,203) |
| Acquisition of businesses, net of cash and restricted cash acquired | — | (5) | (107) |
| Net change in short-term investments | (560) | (334) | 883 |
| Net change in derivative assets and liabilities | 119 | (884) | (754) |
| Other, net | (156) | 262 | (287) |
| Net cash used in investing activities | (11,536) | (5,476) | (7,253) |
| Cash flows from financing activities: | |||
| Proceeds from (payments for): | |||
| Policyholder contract deposits | 39,552 | 33,015 | 26,582 |
| Policyholder contract withdrawals | (28,136) | (27,957) | (20,722) |
| Issuance of long-term debt | 1,329 | 1,240 | 7,451 |
| Issuance of short-term debt | — | — | 1,512 |
| Issuance of debt of consolidated investment entities | 231 | 221 | 946 |
| Repayments of short-term debt | (250) | (1,250) | (8,312) |
| Maturities and repayments of debt of consolidated investment entities | (982) | (535) | (1,228) |
| Dividends paid on common stock | (544) | (1,722) | (876) |
| Distributions to noncontrolling interests | (199) | (91) | (477) |
| Contributions from noncontrolling interests | 70 | 96 | 146 |
| Net change in securities lending and repurchase agreements | 567 | (544) | (647) |
| Issuance of common stock | 1 | — | — |
| Repurchase of common stock | (1,792) | (498) | — |
| Other, net | (267) | 139 | 299 |
| Net cash provided by (used in) financing activities | 9,580 | 2,114 | 4,674 |
| Effect of exchange rate changes on cash and restricted cash | 1 | 3 | (10) |
| Net increase (decrease) in cash and restricted cash | 196 | (2) | 32 |
| Cash and restricted cash at beginning of year | 628 | 633 | 601 |
| Change in cash of businesses held for sale | — | (3) | — |
| Cash and restricted cash at end of year | $824 | $628 | $633 |
Corebridge | 2024 Form 10-K 156
| Supplementary Disclosure of Consolidated Cash Flow Information | |||
|---|---|---|---|
| Years Ended December 31, | |||
| (in millions) | 2024 | 2023 | 2022 |
| Cash | $806 | $612 | $552 |
| Restricted cash included in short-term investments | 4 | 3 | 69 |
| Restricted cash included in other assets | 14 | 13 | 12 |
| Total cash and restricted cash shown in the Consolidated Statements of Cash Flows | $824 | $628 | $633 |
| Cash (received) paid during the period for: | |||
| Interest | $538 | $583 | $472 |
| Taxes | $252 | $20 | $1,101 |
| Non-cash investing activities: | |||
| Fixed maturity securities, designated available-for-sale, received in connection with pension risk transfer transactions | $(1,316) | $(4,317) | $(1,121) |
| Fixed maturity securities, designated available-for-sale, received in connection with reinsurance transactions | $— | $— | $(108) |
| Fixed maturity securities, designated fair value option, received in connection with reinsurance transactions | $(232) | $(93) | $— |
| Fixed maturity securities, designated available-for-sale, transferred in connection with reinsurance transactions | $210 | $439 | $204 |
| Fixed maturity securities, designated fair value option, transferred in connection with reinsurance transactions | $194 | $— | $— |
| Fixed maturity securities, designated available-for-sale, transferred to repay debt of consolidated investment entities | $— | $— | $458 |
| Investment assets transferred in conjunction with fund establishment | $— | $— | $19 |
| Investment assets received in conjunction with fund establishment | $— | $— | $(49) |
| Real estate investments transferred in conjunction with fund establishment | $— | $— | $305 |
| Equity securities distributed in lieu of cash to non-consolidated Corebridge affiliate | $— | $— | $94 |
| Other invested assets securities distributed in lieu of cash to non-consolidated Corebridge affiliate | $— | $— | $694 |
| Other invested assets securities, transferred in connection with reinsurance transactions | $43 | $111 | $— |
| Non-cash financing activities: | |||
| Interest credited to policyholder contract deposits included in financing activities | $5,141 | $4,501 | $3,676 |
| Fee income debited to policyholder contract deposits included in financing activities | $(2,879) | $(2,122) | $(1,694) |
| Non-cash capital contributions | $18 | $16 | $— |
| Distribution in lieu of cash, in equity securities, to non-consolidated Corebridge affiliate | $— | $— | $(94) |
| Distribution in lieu of cash, in Other invested assets securities, to non-consolidated Corebridge affiliate | $— | $— | $(694) |
| Extinguishment of debt in exchange for partnership interest | $— | $— | $(172) |
| Redemption of noncontrolling interests in exchange for partnership interest | $— | $— | $(104) |
Corebridge | 2024 Form 10-K 157
- Overview and Basis of Presentation
Corebridge Financial, Inc. (“Corebridge Parent”) is a leading provider of retirement solutions and life insurance products in the United States. Our primary business operations consist of sales of individual and group annuities products, life insurance products to individuals and institutional markets products. Corebridge Parent common stock, par value $0.01 per share, is listed on the New York Stock Exchange (NYSE: CRBG). The terms “Corebridge,” “we,” “us,” “our” or the “Company” mean Corebridge Parent and its consolidated subsidiaries, unless the context refers to Corebridge Parent only. Subsidiaries of Corebridge Parent include: AGC Life Insurance Company (“AGC”), American General Life Insurance Company (“AGL”), The Variable Annuity Life Insurance Company (“VALIC”), The United States Life Insurance Company in the City of New York (“USL”), Corebridge Insurance Company of Bermuda, Ltd. ("CRBG Bermuda") and SAFG Capital LLC and its subsidiaries. American International Group, Inc. (“AIG Parent”) is a publicly traded entity, listed on the New York Stock Exchange (NYSE: AIG). The term “AIG” means AIG Parent and its consolidated subsidiaries, unless the context refers to AIG Parent only.
On September 19, 2022, we completed an initial public offering (the “IPO”) in which AIG Parent sold 80.0 million shares of Corebridge Parent common stock to the public. Since our IPO, AIG Parent has sold portions of its interest in Corebridge through secondary public offerings and other transactions. As of December 31, 2024, AIG Parent owned approximately 22.7% of the outstanding Corebridge Parent common stock.
On December 9, 2024 (the “Closing Date”), Nippon Life Insurance Company, a mutual company organized under the laws of Japan (“Nippon”), in accordance with that stock purchase agreement (the “Purchase Agreement”), dated as of May 16, 2024, completed its purchase of approximately 122 million shares of Corebridge Parent common stock, beneficially owned by AIG Parent, representing 21.6% of the issued and outstanding Corebridge Parent common stock at signing (the “Nippon Transaction”). As of December 31, 2024, Nippon owned approximately 21.7% of the outstanding Corebridge Parent common stock.
On May 16, 2024, in connection with the execution of the Purchase Agreement, the Company entered into an Amendment to the Separation Agreement, dated as of September 14, 2022, by and between the Company and AIG Parent (the “Separation Agreement”), pursuant to which the Company and AIG Parent agreed to certain changes with respect to AIG’s board designation rights and AIG’s right to consent over certain actions by the Company, as set forth in the Separation Agreement.
On June 9, 2024, AIG Parent waived its right under the Separation Agreement to include a majority of the candidates on each slate of candidates recommended by the Corebridge Board of Directors to Corebridge’s stockholders in connection with a meeting of stockholders. On June 10, 2024, AIG Parent announced that it has met the requirements for the deconsolidation for accounting purposes of Corebridge.
BASIS OF PRESENTATION
These Consolidated Financial Statements include the results of Corebridge Parent, its controlled subsidiaries (generally through a greater than 50% ownership of voting rights and voting interests) and variable interest entities (“VIEs”) of which we are the primary beneficiary. Equity investments in entities that we do not consolidate, including corporate entities in which we have significant influence and partnership and partnership-like entities in which we have more than minor influence over the operating and financial policies, are accounted for under the equity method unless we have elected the fair value option.
The accompanying Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (‘‘GAAP’’). All material intercompany accounts and transactions between consolidated entities have been eliminated.
The accompanying Consolidated Financial Statements reflect all normal recurring adjustments, including eliminations of material intercompany accounts and transactions, necessary in the opinion of management for a fair statement of our financial position, results of operations and cash flows for the periods presented.
SIGNIFICANT TRANSACTIONS
AIG Life U.K.
On September 25, 2023 Corebridge announced that it had entered into a definitive agreement to sell AIG Life U.K., to Aviva plc. On April 8, 2024, Corebridge completed the sale of AIG Life Limited (“AIG Life U.K.”) to Aviva plc (“Aviva”) and received gross proceeds of £453 million ($569 million) resulting in a pre-tax gain of $246 million for the year ended December 31, 2024.
Laya
On October 31, 2023, Corebridge completed the sale of Laya to AXA and received gross proceeds (i.e., net cash before transaction costs) of €691 million ($731 million), resulting in a pre-tax gain of $652 million for the year ended December 31, 2023.
Dividend and Affiliated Note
On November 1, 2021, Corebridge Parent declared a dividend payable to AIG in the amount of $8.3 billion. In connection with that dividend, Corebridge Parent issued a promissory note to AIG Parent in the amount of $8.3 billion. The promissory note to AIG Parent was paid in full during 2022.
Ownership of Fortitude Holdings
On March 31, 2022, our ownership interest in FGH Parent, L.P., (“Fortitude Re Bermuda”) was reduced from 3.5% to 2.46% due to a round of equity financing by third-party investors, in which we did not participate.
Transfer of AIG Technologies, Inc and Eastgreen, Inc.
On February 28, 2022, Corebridge and AIG entered into agreements under which we purchased AIG Technologies, Inc. (“AIGT”) and Eastgreen, Inc. (“Eastgreen”) for total consideration of $107 million. AIGT provides data processing, technology and infrastructure services to Corebridge and AIG entities in the United States, including management of AIG hardware and networks.
HELD-FOR-SALE CLASSIFICATION
Assets classified as held-for-sale are segregated and reported in Assets held-for-sale in our Consolidated Balance Sheets beginning in the period in which the assets are classified as held-for-sale. At December 31, 2024, we recorded Assets held-for-sale, primarily consisting of real estate, of $198 million. At December 31, 2023, we recorded Assets held-for-sale and Liabilities held-for-sale, primarily consisting of AIG Life U.K. and real estate, of $2.2 billion and $1.7 billion, respectively.
USE OF ESTIMATES
The preparation of financial statements in accordance with GAAP requires the application of accounting policies that often involve a significant degree of judgment. Accounting policies that we believe are most dependent on the application of estimates and assumptions are considered our critical accounting estimates and are related to the determination of:
fair value measurements of certain financial assets and liabilities;
valuation of market risk benefits (“MRBs”) related to guaranteed benefit features of variable annuity, fixed annuity and fixed index annuity products;
valuation of embedded derivative liabilities for fixed index annuity, registered index linked annuity and index universal life products;
valuation of future policy benefit liabilities and recognition of remeasurement gains and losses;
reinsurance assets, including the allowance for credit losses;
allowance for credit losses primarily on loans and available-for-sale fixed maturity securities; and
income tax assets and liabilities, including recoverability of our net deferred tax asset and the predictability of future tax operating profitability of the character necessary to realize the net deferred tax asset.
These accounting estimates require the use of assumptions about matters, some of which are highly uncertain at the time of estimation. To the extent actual experience differs from the assumptions used, our consolidated financial condition, results of operations and cash flows could be materially affected.
OUT-OF-PERIOD ADJUSTMENTS
For the year ended December 31, 2024, the Company recorded an $77 million out-of-period adjustment, which increased earnings, primarily related to the correction of net investment income for certain securities and corrections related to the calculation of certain actuarially determined balances. The Company evaluated the impact of the error and out-of-period adjustment and concluded it was not material to any previously issued interim or annual consolidated financial statements and the adjustment was not material to the year ended December 31, 2024.
Corebridge | 2024 Form 10-K 158
- Summary of Significant Accounting Policies
The following identifies our significant accounting policies presented in other Notes to these Consolidated Financial Statements, with a reference to the Note where a detailed description can be found:
Note 5. Investments
Fixed maturity and equity securities
Other invested assets
Net investment income
Net realized gains (losses)
Allowance for credit losses/Other-than-temporary impairments
Note 6. Lending Activities
Mortgage and other loans receivable – net of allowance
Note 7. Reinsurance
Reinsurance assets – net of allowance
Note 8. Variable Interest Entities
Note 9. Derivatives and Hedge Accounting
Derivative assets and liabilities, at fair value
Note 10. Deferred Policy Acquisition Costs
Deferred policy acquisition costs (“DAC”)
Value of business acquired (“VOBA”)
Deferred sales inducements (“DSI”)
Non-deferrable insurance commissions
Note 11. Separate Account Assets and Liabilities
Note 12. Future Policy Benefits
Note 13. Policyholder Contract Deposits and Other Policyholder Funds
Policyholder contract deposits
Other policyholder funds
Variable annuities
Fixed annuity and fixed index annuities
Note 14. Market Risk Benefits
Note 15. Debt
Short-term and Long-term debt
Debt of consolidated investment entities
Note 16. Contingencies, Commitments and Guarantees
Legal contingencies
Note 18. Earnings Per Common Share
Note 22. Income Taxes
OTHER SIGNIFICANT ACCOUNTING POLICIES
Insurance revenues include premiums and policy fees. All premiums and policy fees are presented net of reinsurance, as applicable. Premiums from long-duration life products, other than universal and variable life contracts, are recognized as revenues when due. Premiums from individual and group annuity contracts that are life contingent are recognized as revenues when due.
For limited payment contracts, premiums are due over a significantly shorter period than the period over which benefits are provided. The difference between the gross premium received and recorded as revenue and the net premium is deferred and recognized in policyholder benefits in a constant relationship to insurance in-force, or for annuities, the amount of expected future policy benefits. This Deferred Profit Liability (“DPL”) is recorded in the Consolidated Balance Sheets in Future policy benefits for life and accident and health insurance contracts.
Corebridge | 2024 Form 10-K 159
Premiums on short-duration accident and health policies are earned primarily on a pro rata basis over the term of the related coverage. The reserve for unearned premiums includes the portion of premiums written relating to the unexpired terms of coverage. This unearned revenue reserve (“URR”) is recorded in the Consolidated Balance Sheets in Other policyholder funds.
All reinsurance premiums ceded are recognized when due, following a ceded net premium ratio (“NPR”) methodology that also accrues a proportionate amount of estimated benefits.
Reinsurance premiums for assumed business are estimated based on information received from ceding companies and reinsurers. Any subsequent differences that arise regarding such estimates are recorded in the periods in which they are determined.
Amounts received as payment for investment-oriented contracts such as universal life, variable annuities, fixed annuities, fixed index annuities and registered index linked annuities, are reported as deposits to Policyholder contract deposits or Separate account liabilities, as applicable. Revenues from these contracts are recorded in policy fees and consist of policy charges for the cost of insurance, policy administration charges, surrender charges and amortization of URR. Policy fees are recognized as revenues in the period in which they are assessed against policyholders, unless the fees are designed to compensate Corebridge for services to be provided in the future. Fees deferred as unearned revenue are amortized on a constant level basis over the estimated lives of the contracts, consistent with the amortization of deferred acquisition costs. This URR is recorded in the Consolidated Balance Sheets in Other policyholder funds.
Advisory fee income includes fees from registered investment services.
Other income includes 12b-1 fees (i.e. marketing and distribution fee income), other asset management fee income, and commission-based broker-dealer services.
Advisory fee expense includes primarily sub-advisory fee expenses.
Cash represents cash on hand and demand deposits.
Short-term investments include highly liquid securities and other investments maturing within one year. Securities included within short-term investments are stated at estimated fair value, while other investments included within short-term investments are stated at amortized cost, which approximates estimated fair value.
Premiums and other receivables – net of allowance include premium balances receivable, amounts due from agents and brokers and policyholders, and other receivables.
Other assets consist of deferred sales inducement assets, prepaid expenses, deposits, other deferred charges, other fixed assets, capitalized software costs, goodwill, intangible assets other than goodwill, restricted cash and derivative assets.
Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is tested for impairment at the reporting unit level, which is defined as an operating segment or one level below, and the test is performed annually on July 1, or more frequently if circumstances indicate an impairment may have occurred.
The impairment assessment involves an option to first assess qualitative factors to determine whether events or circumstances exist that lead to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount.
If the qualitative test is not performed or if the test indicates a potential impairment is present, we estimate the fair value of each reporting unit and compare the estimated fair value with the carrying amount of the reporting unit, including allocated goodwill. The estimate of a reporting unit’s fair value involves management judgment and is based on one or a combination of approaches including discounted expected future cash flows, market-based earnings multiples of the unit’s peer companies, external appraisals or, in the case of reporting units being considered for sale, third-party indications of fair value, if available. We consider one or more of these estimates when determining the fair value of a reporting unit to be used in the impairment test. We performed our annual goodwill impairment tests of all reporting units and concluded that our goodwill was not impaired.
Capitalized software costs represent costs directly related to obtaining, developing or upgrading internal use software, are capitalized and amortized using the straight-line method over a period generally not exceedingten years.
Real estate includes the cost of buildings and furniture and fixtures which is depreciated principally using the straight-line basis over their estimated useful lives (maximum of 40 years for buildings,10 years for furniture and fixtures and 5 years for office equipment). Expenditures for maintenance and repairs are charged to income as incurred and expenditures for improvements are capitalized and depreciated. We periodically assess the carrying amount of our real estate for purposes of determining any asset impairment.
Separate accounts represent funds for which investment income and investment gains and losses accrue directly to the policyholders who bear the investment risk. Each account has specific investment objectives and the assets are carried at fair value. The assets of each account are legally segregated and are not subject to claims that arise from any of our other businesses. The liabilities for these accounts are equal to the account assets. Separate accounts may also include deposits for funds held under stable value wrap funding agreements, although the majority of stable value wrap sales are measured based on the notional amount included in assets under management and do not include the receipt of funds.
For a more detailed discussion of separate accounts see Note 11.
Corebridge | 2024 Form 10-K 160
Other liabilities consist of other funds on deposit, other payables, securities sold under agreements to repurchase, securities sold but not yet purchased and derivative liabilities.
Securities sold but not yet purchased represent sales of securities not owned at the time of sale. The obligations arising from such transactions are recorded on a trade-date basis and carried at fair value. Fair values of securities sold but not yet purchased are based on current market prices.
Foreign currency: Financial statement accounts expressed in foreign currencies are translated into U.S. dollars. Functional currency assets and liabilities are translated into U.S. dollars generally using rates of exchange prevailing at the balance sheet date of each respective subsidiary and the related translation adjustments are recorded as a separate component of Accumulated other comprehensive income, net of any related taxes, in Shareholders’ Equity. Income statement accounts expressed in functional currencies are translated using average exchange rates during the period. Functional currencies are generally the currencies of the local operating environment. Financial statement accounts expressed in currencies other than the functional currency of a consolidated entity are remeasured into that entity’s functional currency resulting in exchange gains or losses recorded in income, except for remeasurement gains or losses attributable to available-for-sale securities which are included in Accumulated other comprehensive income (“AOCI”).
Non-redeemable noncontrolling interest is the portion of equity (net assets) and net income (loss) in a subsidiary not attributable, directly or indirectly, to Corebridge.
Redeemable noncontrolling interest represents noncontrolling interest holders in certain consolidated investment entities where the noncontrolling interest holder has the ability to redeem its interest in the consolidated investment entity at its option.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.